Edition:
United States

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

11.51USD
10:40am EST
Change (% chg)

$-0.02 (-0.17%)
Prev Close
$11.53
Open
$11.26
Day's High
$11.56
Day's Low
$11.19
Volume
35,363
Avg. Vol
283,347
52-wk High
$22.75
52-wk Low
$9.64

Chart for

About

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of... (more)

Overall

Beta: 0.43
Market Cap(Mil.): $739.13
Shares Outstanding(Mil.): 62.69
Dividend: --
Yield (%): --

Financials

  DVAX.OQ Industry Sector
P/E (TTM): -- 79.36 29.34
EPS (TTM): -2.36 -- --
ROI: -71.44 -0.30 13.58
ROE: -97.10 -2.98 15.11

Earnings vs. Estimates